Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial

Fig. 3

Forest plots showing a subgroup analysis of overall survival. ECOG-PS, Eastern Cooperative Oncology Group-Performance Status; HCV, hepatitis C virus; AFP, alpha-fetoprotein; DCP, des-gamma carboxy-prothrombin; PVTT, portal vein tumor thrombosis. The HRs were calculated by univariate cox regression analysis

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us